Matrix Laboratories receives USFDA approvals for AIDS Relief vaccine

Details

Category: USFDA Approvals

Matrix Laboratories, a subsidiary of Myland India has received approval from USFDA for AIDS relief vaccine - Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 200 mg /300 mg. These are generic medicine versions of Gilead Sciences Inc’s Truvada tablets which are used to control aids with other medications. Around 30% of AIDS patients in developing countries depend on Matrix anti retroviral products.

• < Prev
• Next >